Articles On Micro-X (ASX:MX1)

New research indicates Imagion Biosystems’ (ASX: IBX)  imaging particles could bring down Tesla — in MRIs that is, not the car brand. A University of Sydney study shows Imagion’s iron oxide nanoparticles enable low-field magnetic resonance...

Australian x-ray products manufacturer Micro-X Ltd [ASX:MX1] has had its share price open higher today thanks to record time FDA approval for its ‘Rover’ device. MX1 designs and develops lightweight x-ray products for global healthcare and...

Australian technology company Micro-X (ASX: MX1) has obtained early approval from the United States Food and Drug Administration (FDA) to sell its Rover mobile medical x-ray device in the US. The company lodged its 510(k) submission for the...

Portable x-ray manufacturer Micro-X (ASX:MX1) has announced its Rover product has been given FDA 510(k) clearance in just five weeks. Rover is intended for defence forces that build temporary medical facilities and require portable equipmen...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The market...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The life s...

Bell Financial Group (ASX:BFG) is expecting to book a higher $23.5m first-half profit, but investors didn’t seem overly happy about it with shares dipping 5.2 per cent on Friday morning. The figure is 5 per cent up on the same period last y...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Victoria h...

Since restrictions on elective surgery were lifted, some stocks in the elective surgery space have seen windfalls that may cancel out the COVID-19 losses. In late March, the Morrison government imposed restrictions on elective surgery to fr...

The past fortnight has seen another interesting list of buyers and sellers. Angel Seafood (ASX:AS1) CEO Issac Lee Halman had to sell $195,000 in shares to pay a tax bill. The company said he had no other choice because the majority of his a...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Now invest...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

Participating in small cap raises is proving lucrative for investors, with shares in 47 small caps that tapped equity markets in April currently trading higher than the price at which they raised cash. Stockhead counted at least 66 offers i...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Cochlear’s...

Pre-revenue biotech and medtech companies are still not eligible for the Jobkeeper wage subsidy according to the ATO, a double whammy for a swathe of research-driven ASX businesses with large staff costs. The Jobkeeper program allows busine...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve keen keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

It’s still a relatively difficult market to raise capital in, particularly at the junior end, but there are some that have convinced investors to part with their hard earned cash. We run through just which small and micro caps successfully...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   This week’s three big themes...

Morgans Senior Analyst Scott Power updates the network with information on 3 companies: Volpara (ASX:VHT), Impedimed (ASX:IPD) and Micro-X (ASX:MX1).

Listed X-ray technology company Micro-X Ltd was in the market on Wednesday, seeking $15 million of new equity.

Micro-X Ltd (ASX: MX1), an Australian hi-tech company, on 7 April 2020, announced to have received purchase orders valued at $1.2 million for the Carestream DRX Revolution Nano, majorly for Australian customers. Of the total, MX1 secured pu...

X-ray technology company Micro-X (ASX: MX1) has posted stronger-than-expected first quarter results as orders for its mobile x-ray system grow “substantially” in response to coronavirus-stimulated demand. The company said the rapidly growin...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Coronavirus continues to drive sales into Asia and Europe for South Australian hi-tech x-ray manufacturer Micro-X. The Adelaide-based company reported to the ASX last week that sales of its flagship lightweight mobile x-ray machine had reac...

As with the early medical cannabis plays, a cluster of ASX-listed stocks has wasted little time attaching itself to the ‘c’ word. We’re talking of course about the coronavirus COVID-19 but sadly not another ‘c’ word: cure. Or not yet. Accor...

Micro-X (ASX: MX1) has collared an additional $1 million in sales for its mobile x-ray technology as governments worldwide scramble to get on top of the coronavirus COVID-19 outbreak. The additional $1 million order follows purchase orders...

Neuroscience tech company Cogstate (ASX:CGS) produced some much needed good news today, saying it has executed $9.1m of clinical trials sales contracts since the start of 2020. The stock — up about 30 per cent on the news — says this revenu...

You don’t need a PhD to run a biotech, but sometimes it helps, as these companies deal in one of the most complicated mysteries still to be solved today: the human body. Biotech CEOs and chairs tend to be the cross-over scientists. However,...

Did you know that a hard-working stallion ejaculates 100 times more sperm than the average bloke? Given a virile, but weary, thoroughbred can service hundreds of mares in a breeding season, that’s just as well. But even the most virile of t...

Stockbroker Morgans is expected to close the books on an equity raising for lightweight X-ray products maker Micro-X.

Australian high-tech company Micro-X Ltd (ASX: MX1) has informed that it is amending the Convertible Loan Agreement with Thales AVS France SAS completed on the 2 July 2019 so that the convertible security under the Loan Agreement does not t...

In Australia, there are plenty of high-quality health care companies, most of which have delivered excellent returns. Investment in health care stocks is high yielding; however, it does include risks. If undergoing clinical studies fail to...

People in Sydney and Melbourne might think of Adelaide as home to little more than football, wines and an electricity network that isn’t always up to scratch. But as Lanyon Asset Management managing director David Prescott noted, the world’...

Zelda Therapeutics Ltd (ASX: ZLD) Cannabis Group Zelda Therapeutics released its quarterly results for the three months ended 30 June 2019. The company reported a continued progress in its core clinical and preclinical programs and is in th...

Queenstown is known as the adventure capital of the world. It attracts over three million people per year to experience the world-class ski runs, zip-line riding, white water rafting, sky diving and is, of course, famous for manufacturing t...

Business magnate Warren Buffet advised the investors to absolutely refrain from investing in a business that they are unable to understand. This would resonate with the mind and willingness of every active investor, as they all practice the...